Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 25 studies | 52% ± 27% | |
connective tissue cell | 11 studies | 51% ± 29% | |
myofibroblast cell | 6 studies | 29% ± 12% | |
ciliated cell | 6 studies | 27% ± 8% | |
progenitor cell | 5 studies | 51% ± 27% | |
pericyte | 5 studies | 30% ± 15% | |
epithelial cell | 4 studies | 57% ± 18% | |
mesothelial cell | 4 studies | 68% ± 10% | |
smooth muscle cell | 4 studies | 34% ± 4% | |
kidney loop of Henle epithelial cell | 3 studies | 22% ± 5% | |
endothelial cell | 3 studies | 28% ± 12% | |
basal cell | 3 studies | 32% ± 9% | |
Mueller cell | 3 studies | 20% ± 1% | |
chondrocyte | 3 studies | 46% ± 18% | |
myoepithelial cell | 3 studies | 35% ± 26% | |
adipocyte | 3 studies | 34% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 13119.26 | 577 / 578 | 70% | 98.56 | 807 / 1155 |
breast | 100% | 7079.64 | 459 / 459 | 56% | 33.89 | 627 / 1118 |
kidney | 92% | 3268.79 | 82 / 89 | 28% | 12.92 | 256 / 901 |
bladder | 86% | 1602.38 | 18 / 21 | 30% | 23.39 | 150 / 504 |
ovary | 69% | 1526.21 | 124 / 180 | 41% | 30.94 | 178 / 430 |
thymus | 93% | 2612.70 | 606 / 653 | 12% | 2.82 | 73 / 605 |
adipose | 100% | 8879.17 | 1204 / 1204 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.62 | 1 / 1 |
stomach | 63% | 992.31 | 227 / 359 | 37% | 29.61 | 105 / 286 |
adrenal gland | 65% | 1063.86 | 167 / 258 | 32% | 24.86 | 74 / 230 |
pancreas | 28% | 335.53 | 93 / 328 | 68% | 115.14 | 121 / 178 |
uterus | 42% | 612.85 | 71 / 170 | 47% | 59.15 | 214 / 459 |
liver | 4% | 44.60 | 9 / 226 | 83% | 682.83 | 336 / 406 |
skin | 58% | 1175.84 | 1046 / 1809 | 28% | 24.21 | 130 / 472 |
prostate | 38% | 534.35 | 94 / 245 | 39% | 7.15 | 196 / 502 |
esophagus | 28% | 500.43 | 407 / 1445 | 46% | 66.47 | 85 / 183 |
intestine | 31% | 452.61 | 303 / 966 | 27% | 12.80 | 140 / 527 |
blood vessel | 58% | 1308.26 | 769 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 49% | 41.62 | 22 / 45 |
heart | 48% | 1001.60 | 415 / 861 | 0% | 0 | 0 / 0 |
spleen | 15% | 239.96 | 37 / 241 | 0% | 0 | 0 / 0 |
brain | 1% | 15.30 | 29 / 2642 | 7% | 4.94 | 52 / 705 |
muscle | 7% | 91.06 | 53 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.20 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0050673 | Biological process | epithelial cell proliferation |
GO_0072180 | Biological process | mesonephric duct morphogenesis |
GO_0001658 | Biological process | branching involved in ureteric bud morphogenesis |
GO_0007224 | Biological process | smoothened signaling pathway |
GO_0009948 | Biological process | anterior/posterior axis specification |
GO_0030324 | Biological process | lung development |
GO_0046326 | Biological process | positive regulation of glucose import |
GO_0030316 | Biological process | osteoclast differentiation |
GO_0090263 | Biological process | positive regulation of canonical Wnt signaling pathway |
GO_0009617 | Biological process | response to bacterium |
GO_0045879 | Biological process | negative regulation of smoothened signaling pathway |
GO_0072111 | Biological process | cell proliferation involved in kidney development |
GO_0045807 | Biological process | positive regulation of endocytosis |
GO_0060976 | Biological process | coronary vasculature development |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0050680 | Biological process | negative regulation of epithelial cell proliferation |
GO_0035116 | Biological process | embryonic hindlimb morphogenesis |
GO_0060070 | Biological process | canonical Wnt signaling pathway |
GO_0072138 | Biological process | mesenchymal cell proliferation involved in ureteric bud development |
GO_0045880 | Biological process | positive regulation of smoothened signaling pathway |
GO_0045732 | Biological process | positive regulation of protein catabolic process |
GO_2000050 | Biological process | regulation of non-canonical Wnt signaling pathway |
GO_0010171 | Biological process | body morphogenesis |
GO_2000096 | Biological process | positive regulation of Wnt signaling pathway, planar cell polarity pathway |
GO_0042074 | Biological process | cell migration involved in gastrulation |
GO_0030282 | Biological process | bone mineralization |
GO_0030513 | Biological process | positive regulation of BMP signaling pathway |
GO_0072203 | Biological process | cell proliferation involved in metanephros development |
GO_1905475 | Biological process | regulation of protein localization to membrane |
GO_0009653 | Biological process | anatomical structure morphogenesis |
GO_0060071 | Biological process | Wnt signaling pathway, planar cell polarity pathway |
GO_0045926 | Biological process | negative regulation of growth |
GO_0060828 | Biological process | regulation of canonical Wnt signaling pathway |
GO_0016477 | Biological process | cell migration |
GO_0005886 | Cellular component | plasma membrane |
GO_0005796 | Cellular component | Golgi lumen |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0009986 | Cellular component | cell surface |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0043202 | Cellular component | lysosomal lumen |
GO_0098552 | Cellular component | side of membrane |
GO_0060422 | Molecular function | peptidyl-dipeptidase inhibitor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | GPC3 |
Protein name | Glypican-3 Glypican-3 (GTR2-2) (Intestinal protein OCI-5) (MXR7) [Cleaved into: Glypican-3 alpha subunit; Glypican-3 beta subunit] |
Synonyms | hCG_14619 OCI5 |
Description | FUNCTION: Cell surface proteoglycan. . FUNCTION: Cell surface proteoglycan . Negatively regulates the hedgehog signaling pathway when attached via the GPI-anchor to the cell surface by competing with the hedgehog receptor PTC1 for binding to hedgehog proteins (By similarity). Binding to the hedgehog protein SHH triggers internalization of the complex by endocytosis and its subsequent lysosomal degradation (By similarity). Positively regulates the canonical Wnt signaling pathway by binding to the Wnt receptor Frizzled and stimulating the binding of the Frizzled receptor to Wnt ligands . Positively regulates the non-canonical Wnt signaling pathway (By similarity). Binds to CD81 which decreases the availability of free CD81 for binding to the transcriptional repressor HHEX, resulting in nuclear translocation of HHEX and transcriptional repression (By similarity). Inhibits the dipeptidyl peptidase activity of DPP4 . Plays a role in limb patterning and skeletal development by controlling the cellular response to BMP4 (By similarity). Modulates the effects of growth factors BMP2, BMP7 and FGF7 on renal branching morphogenesis (By similarity). Required for coronary vascular development (By similarity). Plays a role in regulating cell movements during gastrulation (By similarity). . FUNCTION: Cell surface proteoglycan. . FUNCTION: Cell surface proteoglycan. . FUNCTION: Cell surface proteoglycan. . FUNCTION: Cell surface proteoglycan. . FUNCTION: Cell surface proteoglycan. . FUNCTION: Cell surface proteoglycan. . FUNCTION: Cell surface proteoglycan. . |
Accessions | B4DTD8 ENST00000689310.1 A0A1S5UZ08 ENST00000406757.3 ENST00000394299.7 [P51654-3] Q53H15 Q8IYG2 A0A8I5KYY0 ENST00000631057.2 [P51654-2] ENST00000370818.8 [P51654-1] H0Y3U6 I6QTG3 P51654 ENST00000684880.1 A0A8I5KUG1 ENST00000692084.1 |